Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2052 ARTÍCULOS , VIENDO DEL 466 AL 480

Review: Investigating the aggregation of amyloid beta with surface plasmon resonance: Do different approaches yield different results?

Young KA, Mancera RL.

Anal Biochem. 2022 Oct 1;654:114828. doi: 10.1016/j.ab.2022.114828. Epub 2022 Aug 2.

Neuropathologic Changes Provide Insights into Key Mechanisms of Alzheimer Disease and Related Dementia

Plascencia-Villa G, Perry G.

Am J Pathol. 2022 Oct;192(10):1340-1346. doi: 10.1016/j.ajpath.2022.07.002. Epub 2022 Aug 2.

Alzheimer's disease failed clinical trials

Asher S, Priefer R.

Life Sci. 2022 Oct 1;306:120861. doi: 10.1016/j.lfs.2022.120861. Epub 2022 Aug 4.

Neuropathology in chronic traumatic encephalopathy: a systematic review of comparative post-mortem histology literature

Murray HC, Osterman C, Bell P, Vinnell L, Curtis MA.

Acta Neuropathol Commun. 2022 Aug 6;10(1):108. doi: 10.1186/s40478-022-01413-9.

Generation of human induced pluripotent stem cell lines SPPHIi003-A and SPPHIi004-A from two patients with sporadic Alzheimer's disease in Southwestern China

Chen L, Zhang J, Yang X, Wang S, Ye F.

Stem Cell Res. 2022 Oct;64:102876. doi: 10.1016/j.scr.2022.102876. Epub 2022 Jul 28.

Neuropsychological and Neuroanatomical Features of Patients with Behavioral/Dysexecutive Variant Alzheimer's Disease (AD): A Comparison to Behavioral Variant Frontotemporal Dementia and Amnestic AD Groups

Dominguez Perez S, Phillips JS, Norise C, Kinney NG, Vaddi P, Halpin A, Rascovsky K, Irwin DJ, McMillan CT, Xie L, Wisse LEM, Yushkevich PA, Kallogjeri D, Grossman M, Cousins KAQ.

J Alzheimers Dis. 2022;89(2):641-658. doi: 10.3233/JAD-215728.

The glymphatic system: implications for drugs for central nervous system diseases

Lohela TJ, Lilius TO, Nedergaard M.

Nat Rev Drug Discov. 2022 Oct;21(10):763-779. doi: 10.1038/s41573-022-00500-9. Epub 2022 Aug 10.

Interpreting the Clinical Implications of Drug-Target Mendelian Randomization Studies

Ference BA.

J Am Coll Cardiol. 2022 Aug 16;80(7):663-665. doi: 10.1016/j.jacc.2022.06.007.

The Mechanistic Pathways of Periodontal Pathogens Entering the Brain: The Potential Role of Treponema denticola in Tracing Alzheimer's Disease Pathology

Pisani F, Pisani V, Arcangeli F, Harding A, Singhrao SK.

Int J Environ Res Public Health. 2022 Jul 31;19(15):9386. doi: 10.3390/ijerph19159386.

An Adaptive Role for DNA Double-Strand Breaks in Hippocampus-Dependent Learning and Memory

Weber Boutros S, Unni VK, Raber J.

Int J Mol Sci. 2022 Jul 28;23(15):8352. doi: 10.3390/ijms23158352.

Multitargeting the Action of 5-HT(6) Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer's Disease: Can It Work from a Molecular Point of View?

Czarnota-Łydka K, Kucwaj-Brysz K, Pyka P, Haberek W, Podlewska S, Handzlik J.

Int J Mol Sci. 2022 Aug 7;23(15):8768. doi: 10.3390/ijms23158768.

Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer's Disease Therapy

Moreira P, Matos P, Figueirinha A, Salgueiro L, Batista MT, Branco PC, Cruz MT, Pereira CF.

Int J Mol Sci. 2022 Aug 8;23(15):8812. doi: 10.3390/ijms23158812.

Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology

Hassan NA, Alshamari AK, Hassan AA, Elharrif MG, Alhajri AM, Sattam M, Khattab RR.

Molecules. 2022 Jul 28;27(15):4839. doi: 10.3390/molecules27154839.

Recent advances of small molecule JNK3 inhibitors for Alzheimer's disease

Qin P, Ran Y, Liu Y, Wei C, Luan X, Niu H, Peng J, Sun J, Wu J.

Bioorg Chem. 2022 Nov;128:106090. doi: 10.1016/j.bioorg.2022.106090. Epub 2022 Aug 9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias